Crossmark

A novel pregabalin functionalized salicylaldehyde derivative loaded mesoporous silica nano scaffold: a prospective carrier for targeting inflammatory cytokine storm

Crossref DOI link: https://doi.org/10.1186/s12896-025-01066-1

Published Online: 2025-11-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mehmood, Yasir

Rizvi, Syeda Momena

Ijaz, Musarrat

Shahzadi, Tamseela

Shahid, Hira

Ahmed, Shabbir

Rasul, Akhtar

Iqbal, Javed

Almehizia, Abdulrahman A.

Bouallegue, Amir

Dauelbait, Musaab

Alyami, Esmael M.
Funding

Funding for this research was provided by:

King Saud University (ORF-RC-2025-x)
License Information

Text and Data Mining valid from 2025-11-13

Version of Record valid from 2025-11-13
More Information

Article History

Received: 11 March 2025

Accepted: 29 October 2025

First Online: 13 November 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below